circadian HSC migration 6 . The production of norepinephrine is limited by the activity of the enzyme tyrosine hydroxylase. Heidt et al. 4 found increased expression of both tyrosine hydroxylase and norepinephrine in bone marrow of mice with stress induced by social or environmental factors. Consistent with the known role of norepinephrine as a primary repressor of synthesis of the chemokine CXCL12, they also reported a Our daily lives are filled with stressful situations. Social stress was first linked to cardiovascular disease in animal models by Kaplan et al. 1 , who reported that social stress increased atherosclerosis in monkeys independently of plasma cholesterol levels. Other studies showed that social stress, but not physical stress, accelerated athero sclerosis development in mice 2, 3 . However, the mechanisms for how stress makes our cardiovascular system sick are largely unknown. In this issue of Nature Medicine, Heidt et al. 4 now show that chronic stress activates hematopoietic stem cells (HSCs) in the bone marrow, causing them to differentiate into increased numbers of leukocytes that travel into the blood circulation and contribute to the development of cardiovascular disease (Fig. 1) .
In this study, Heidt et al. 4 first explored the impact of stress on myeloid cell production in humans by studying a highly stressed group of individuals: on-duty medical residents working in a hospital intensive care unit (ICU). Compared to when they were off duty, medical residents actively working in the ICU had higher perceived stress when tested, and examination of their peripheral blood showed an increase in leukocyte numbers, with higher counts of neutrophils, monocytes and lymphocytes. Furthermore, the authors found that chronically stressed mice also had increased numbers of neutrophils, monocytes and lymphocytes in their blood. In mice they discovered that chronic stress also caused proliferation of HSCs, which increased the numbers of committed myeloid and lymphoid progenitor cells in bone marrow.
To find a mechanistic explanation for these observations, the authors focused on the sympathetic nervous system, which produces norepinephrine and other catecholamines during stress. Norepinephrine release from the sympathetic nervous system during neuroinflammation has been associated with increased leukocyte trafficking in mice 5 . Previous studies in mice and humans have shown that norepinephrine also regulates Stress has long been thought to be a major contributing factor to cardiovascular disease, although little is known about the underlying cellular mechanisms. A new study in humans and mice suggests that chronic stress promotes hematopoietic stem cell proliferation in bone marrow, leading to increased leukocyte production, circulation and recruitment to the vasculature (pages 754-758). 4 show that in response to stress the sympathetic nervous system releases norepinephrine in the bone marrow that binds to β 3 -adrenergic receptors in the bone marrow and results in decreased CXCL12 release in hematopoietic stem cell niches. CXCL12 normally functions to control HSC proliferation; thus, reductions in CXCL12 levels results in increased hematopoiesis. The resultant excessive release of inflammatory leukocytes into circulation promotes atherosclerotic plaque inflammation and drives formation of plaques with features characteristic of 'vulnerable lesions' that cause myocardial infarction and stroke. Treatment of chronically stressed mice with β 3 -adrenergic receptor antagonists limits stress-induced cardiovascular disease progression. neutrophil levels correlate with increased risk of cardiovascular disease 9 . Examination of stressed atherosclerosis-susceptible mice lacking apolipoprotein E (ApoE) showed an increase in HSC pro liferation, with no changes in body weight or plasma lipoprotein cholesterol levels after 6 weeks of induced stress and high-fat diet feeding. The authors also observed an increase in numbers of neutrophils and classical monocytes recruited to aortas of stressed mice lacking ApoE. Correspondingly, after 6 weeks of chronic stress, in vivo fluorescence imaging of the mouse aorta showed an increase in plaque protease activity, and analysis of aortic arches showed increased amounts of matrix metalloproteinase 14 (a protease) and myeloperoxidase (a neutrophil marker) in the plaques. Surprisingly, the authors found that the sizes of the atherosclerotic plaques did not change in the stressed mice, but the characteristic features of the plaques were markedly changed. The atherosclerotic plaques in the stressed mice had thinner fibrous caps (probably related to increased protease activity) and larger necrotic cores, both of which are hallmarks of ruptureprone lesions that cause acute myocardial infarction or stroke. These stress-induced effects were negated by β 3 -adrenoreceptor blocker treatment.
This study opens questions as to which transcription factors are mediating leukocyte differentiation in response to stress and whether leukocytes themselves can directly respond to stress. Recent studies in stressed mice suggest that several transcription factors in HSCs and myeloid cells that regulate hematopoiesis, including PU.1, are induced by chronic stress 10 . Expression of the transcription factor NR4A1, which regulates monocyte development in the bone marrow 11 , is induced in human and mouse neurological tissues by stress and stress hormone release 12 . Furthermore, as leukocytes themselves express β-adrenergic receptors, future studies to learn how stress-induced β-adrenergic receptor signaling directly affects leukocyte function in the vasculature would also be of interest. Prior studies by Dimitrov et al. 13 have shown that some monocyte subsets express β 2 -adrenergic drastic reduction in CXCL12 protein in the bone marrow of the stressed mice. CXCL12 functions in the bone marrow to control HSC proliferation 7 and retain leukocytes in the bone marrow 8 .
Catecholamines, including norepinephrine and epinephrine, bind to β-adrenergic receptors to exert their effects. β-adrenergic receptor expression on bone marrow niche cells regulates CXCL12 release, which further links signaling from the sympathetic nervous system to leukocyte trafficking 6 . Within bone marrow niches, the authors found that β 2 -adrenergic receptors are highly expressed in osteoblastic lineage cells, whereas β 3 -adrenergic receptors are highly expressed in mesenchymal stromal cells. Interestingly, mice that lacked the β 3 -adrenergic receptor (Adrb3 −/− mice) were protected against the effects of chronic stress with no changes in HSC proliferation, CXCL12 production or blood leukocyte numbers. Similarly, treatment of wild-type stressed mice with a β 3 -adrenergic receptor antagonist protected them against stress-induced changes in hematopoiesis, whereas treatment with a β 2 -adrenergic receptor antagonist had no effect. Thus, Heidt et al. 4 discovered that selectively blocking β 3 -adrenergic receptors in the bone marrow prevented the stressinduced increases in HSC proliferation and leukocyte release into circulation.
Finally, the authors asked how these hematopoietic changes in response to chronic stress affected atherosclerosis. Atherosclerosis is a chronic inflammatory disease in which leukocytes accumulate in the vessel wall in response to elevated levels of low-density lipoproteins, also known as 'bad' cholesterol. As atherosclerotic plaques containing lipid deposits and immune cells grow over time, they develop a necrotic core filled with cell debris and a fibrous cap that stabilizes the plaque in the vessel wall. However, proteases released from inflammatory leukocytes can weaken the fibrous cap and cause it to rupture, leading to a clotted artery, myocardial infarction or stroke. Decades of research have shown that monocyte interactions with the vascular endothelium are key early events in atherogenesis and that high circulating monocyte and receptors and rapidly appear in circulation from vascular marginal pools, a process called demargination, in response to catecholamine release. Recent studies have also reported that human monocytes isolated from stressed individuals show elevated proinflammatory gene expression 10 . Taken together, such studies and the studies by Heidt et al. 4 suggest that both the production and trafficking of leukocytes and their functions in the vasculature are affected by chronic stress.
Finally, the studies by Heidt et al. 4 have clear clinical implications because they suggest that selectively targeting β 3 -adrenergic receptors may protect against leukocytemediated inflammation associated with atherosclerosis and myocardial infarction. β 1 and β 2 blockers are routinely used for the prevention and management of myocardial infarction and stroke. However, β 3 -adrenergic receptor blockers currently have limited clinical applications. Further studies are needed to determine whether selective β 3 -blockers could have similar effects in reducing stress-induced leukocyte production in humans and, if so, whether they would be useful future therapies for cardiovascular disease and other stress-related inflammatory diseases.
